Schedule 13D ownership disclosure
BELLEROPHON THERAPEUTICS INC
Security class unavailable · CUSIP: 078771300
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,763,077
- Percent of class
- 18.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001760460-21-000003
- Form type
- SC 13D
- Filer
- Bellerophon Therapeutics, Inc.
- CIK
- CIK 1600132
- Filed
- Apr 28, 2021
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership